Watch NUTX. Know when insiders buy.
One email the day a filing lands. Free.
NUTX
Nutex Health Inc.
208.79
−5.53 −2.58%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
46
WATCH · insiders 48, shorts 43
Insiders, 90 days
−$43K
net selling · 0 buys, 1 sell
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E 8.3DIV YIELD —FCF YIELD 19.18%REV TTM $846.7M +6.9%NET INCOME $179.9M +218.8%NET CASH $180.5M52W 87.01 – 217.32SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $210.8M | −13.6% | 67.0% | $121.7M | $65.8M | — | 9.38 | $34.2M | $2.5M | $31.7M | Aug 6 |
| Q1 2026 · Mar 31 | $216.5M | +2.2% | 42.4% | $81.3M | $46.8M | +120.6% | 6.52 | $75.5M | $1.2M | $74.3M | Apr 30 |
| Q4 2025 · Dec 31derived | $151.7M | −41.1% | 30.4% | $30.9M | $11.8M | −80.8% | 1.61 | $70.4M | $1.4M | $69M | Mar 5 |
| Q3 2025 · Sep 30 | $267.8M | +239.9% | 57.8% | $130.4M | $55.4M | — | 7.76 | $99.5M | $302K | $99.2M | Nov 19 |
| Q2 2025 · Jun 30 | $244M | +220.7% | 51.2% | $33.7M | −$17.7M | — | -2.95 | $27.3M | $751K | $26.5M | Aug 6 |
| Q1 2025 · Mar 31 | $211.8M | +214.0% | 55.9% | $80.7M | $21.2M | — | 3.33 | $51M | $64K | $50.9M | Apr 30 |
| Q4 2024 · Dec 31 | $257.6M | +269.8% | 55.0% | $114.2M | $61.7M | — | 11.12 | $54K | $395K | −$341K | Mar 5 |
| Q3 2024 · Sep 30 | $78.8M | +25.6% | 27.8% | $9.7M | −$8.8M | — | -1.72 | $6.8M | $617K | $6.2M | Nov 19 |
| Q2 2024 · Jun 30 | $76.1M | — | 29.7% | $5.3M | −$364K | — | -0.07 | $13.3M | $559K | $12.7M | Nov 18 |
| Q1 2024 · Mar 31 | $67.5M | — | 15.1% | $1.4M | −$364K | — | -0.08 | $3.1M | $733K | $2.3M | Nov 18 |
| Q4 2023 · Dec 31 | $69.7M | — | 19.0% | −$26.1M | −$31.6M | — | -7.47 | −$1.8M | — | — | Mar 5 |
| Q3 2023 · Sep 30 | $62.7M | — | 11.3% | −$821K | −$5.5M | — | -1.25 | $2M | — | — | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $875.3M | 50.8% | $275.6M | $70.8M | 8.1% | 10.48 | $248.1M | $2.5M | $245.6M | $5M | — |
| FY2024 · to Dec 31 | $479.9M | 40.9% | $130.7M | $52.1M | 10.9% | 9.69 | $23.2M | $2.3M | $20.8M | $0 | — |
| FY2023 · to Dec 31 | $247.6M | 14.0% | −$31.8M | −$45.8M | -18.5% | -10.39 | $1.3M | $9.5M | −$8.2M | $0 | — |
| FY2022 · to Dec 31 | $219.3M | 7.0% | −$406.6M | −$424.8M | -193.7% | -100.36 | $50.6M | $14.6M | $36M | — | — |
| FY2021 · to Dec 31 | $331.5M | 54.1% | $170.3M | $132.6M | 40.0% | 0.22 | $173.4M | $36.9M | $136.5M | — | — |
| FY2020 · to Dec 31 | $274M | 57.5% | $153.2M | $106M | 38.7% | 0.18 | $86.7M | $61.2M | $25.5M | — | — |
Every number comes from Nutex Health Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.